Therese Choquette is the Chief Technical Officer at Tigen Pharma (Lausanne, Switzerland) She has a long-standing experience in Cell & Gene Therapy, analytical development and CMC; from early development into the commercial space. Therese obtained a MSc in Biomedicine and PhD in Rheumatology from the Karolinska Institute in Stockholm, Sweden.